Record #3640

A Randomized Phase II Study of Everolimus for Advanced Pancreatic Neuroendocrine Tumors in Chinese Patients

Citation lifecycle

How this paper is being cited

Pre-retraction
1
Same day
0
Post-retraction
11
% post-retraction
91.7%
~1.5 citations/yr before retraction · ~1.0 citations/yr after
citing papers

Who is still citing this work

Loading…